Integra LifeSciences Holdings Corporation announced that the company has expanded its OrthoBiologics product line with the introduction of Integra Mozaik Osteoconductive Scaffold strip in a smaller configuration. Surgeons will now have wider selection of products that will satisfy their bone grafting needs.
Integra Mozaik Osteoconductive Scaffold is intended to fill bone voids or gaps in the skeletal system of the extremities, pelvis and spine. The Scaffold guides the regeneration of new bone across critical defect sites in which it has been implanted. A new bone formation is initiated in the matrix surface when the graft is placed in direct apposition to living host bone. The matrix is remodeled and resorbed as new bone is formed.
Integra Mozaik has the same Type I collagen used in many of company’s innovative regenerative products. Integra Mozaik integrates the highly pure form of beta-tricalcium phosphate with collagen matrix to provide compression resistance and a mineral source, two properties essential for bone healing.
The Scaffold may replace the need to harvest bone from the patient’s iliac crest hence sparing the patient additional surgery and postoperative pain when used with bone marrow aspirate from the patient.
The addition of this new configuration reflects Integra OrthoBiologics’ commitment to expand our orthobiologics portfolio and further Integra’s mission to provide products that improve the quality of life, said Bill Weber, Vice President of Integra OrthoBiologics.
Integra Mozaik Osteoconductive Scaffold is sold in the United States through the Integra OrthoBiologics distributor network.